MedPath

Effect of Different Non-surgical Treatment Approaches of Peri-implantitis

Not Applicable
Completed
Conditions
Peri-implant Inflammation
Peri-Implantitis and Peri-implant Mucositis
Non-surgical Treatment
Registration Number
NCT06730568
Lead Sponsor
Yeditepe University
Brief Summary

Peri-implantitis is a biofilm-associated pathological condition characterized by inflammation within the peri-implant mucosa, which leads to the progressive loss of the surrounding supporting bone tissue. The primary goal of managing peri-implantitis is to control the peri-implant biofilm and resolve inflammation. Nonsurgical treatment of peri-implantitis by submarginal mechanical instrumentation alone typically provides clinical improvements, particularly in non-advanced cases. However, to ensure surface decontamination and enhance treatment outcomes, alternative or adjunctive methods, such as systemic/local antibiotics, antiseptics, lasers, and air-abrasion systems, have been proposed.

Therefore, the null hypothesis (H0) of the present study is that no statistically significant difference would be detected in clinical inflammation signs among patients diagnosed with early-stage peri-implantitis after undergoing one of the following treatments: nonsurgical mechanical instrumentation alone, mechanical instrumentation plus chlorhexidine (CHX), mechanical instrumentation plus gaseous ozone, mechanical instrumentation plus glycine air polishing, or glycine air polishing alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • the presence of at least one titanium implant with clinical and radiographic signs of initial to moderate peri-implantitis
  • single-unit or partial restorations without overhangings
  • absence of occlusal overload
  • the presence of at least 2 mm of keratinized attached peri-implant mucosa
  • periodontally healthy participants with a good level of oral hygiene
Exclusion Criteria
  • the presence of implant mobility
  • systemic diseases (i.e. diabetes (HbA1c <7), osteoporosis, bisphosphonate medication) which could affect the outcome of treatment
  • smoking
  • placement, and prosthetic loading of implants within the past year

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Probable Pocket DepthBaseline, 3 months, and 6 months after treatment
Secondary Outcome Measures
NameTimeMethod
Bleeding on ProbingBaseline, 3 months, and 6 months after treatment
Plaque IndexBaseline, 3 months, and 6 months after treatment

Trial Locations

Locations (1)

Gazi University Dentistry Faculty

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath